Merck (MRK) Enterprise Value Growth (1y) (2010 - 2026)

Merck (MRK) Enterprise Value Growth (1y) (2010 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 38.35%
Dec 31, 2025 -6.45%
Sep 30, 2025 -24.92%
Jun 30, 2025 24.21%
Mar 31, 2025 -64.83%
Dec 31, 2024 -93.64%
Sep 30, 2024 -66.70%
Jun 30, 2024 -78.35%
Mar 31, 2024 46.11%
Dec 31, 2023 46.37%
Sep 30, 2023 22.03%
Jun 30, 2023 37.04%
Mar 31, 2023 -16.46%
Dec 31, 2022 -63.59%
Sep 30, 2022 -12.42%
Jun 30, 2022 -18.54%
Mar 31, 2022 -28.62%
Dec 31, 2021 -0.75%
Sep 30, 2021 -36.78%
Jun 30, 2021 22.91%